The Oncosearch | Oncotarget

High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1 Research Paper

Zhu Liang, Rui Kong, Zhan He, Li-Yao Lin, Shan-Shan Qin, Chun-Yuan Chen, Zhan-Qiang Xie, Fei Yu, Guo-Qian Sun, Chun-Guang Li, Da Fu, Geng-Xi Jiang, Jie Chen, Yu-Shui Ma

Published May 7, 2017 · Vol. 8, No. 29 · pp. 47389-47399

A novel EGFR-TKI inhibitor (cAMP-H₃BO₃ complex) combined with thermal therapy is a promising strategy to improve lung cancer treatment outcomes Research Paper

Yongpeng Tong, Chunliu Huang, Junfang Zhang

Published May 5, 2017 · Vol. 8, No. 34 · pp. 56327-56337

Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC) Research Paper

Carles Codony-Servat, Jordi Codony-Servat, Niki Karachaliou, Miguel Angel Molina, Imane Chaib, Jose Luis Ramirez, Maria de los Llanos Gil, Flavio Solca, Trever G. Bivona, Rafael Rosell

Published May 4, 2017 · Vol. 8, No. 29 · pp. 47305-47316

Expression of glucose transporter 1 and prognosis in non-small cell lung cancer: a pooled analysis of 1665 patients Research Paper

Zhibo Tan, Chao Yang, Xiaohan Zhang, Pingju Zheng, Weixi Shen

Published May 4, 2017 · Vol. 8, No. 37 · pp. 60954-60961

Prognostic value of KRAS mutation in advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A meta-analysis and review Meta-Analysis

Jung Han Kim, Hyeong Su Kim, Bum Jun Kim

Published May 3, 2017 · Vol. 8, No. 29 · pp. 48248-48252

Mathematical modeling for Phase I cancer trials: A study of metronomic vinorelbine for advanced non-small cell lung cancer (NSCLC) and mesothelioma patients Research Paper

Fabrice Barlesi, Diane-Charlotte Imbs, Pascale Tomasini, Laurent Greillier, Melissa Galloux, Albane Testot-Ferry, MÃ©lanie Garcia, Xavier Elharrar, Annick Pelletier, Nicolas AndrÃ©, CÃ©line Mascaux, Bruno Lacarelle, Raouf El Cheikh, RaphaÃ«l Serre, Joseph Ciccolini, Dominique Barbolosi

Published May 2, 2017 · Vol. 8, No. 29 · pp. 47161-47166

Circulating microRNAs as novel biomarkers of ALK-positive non-small cell lung cancer and predictors of response to crizotinib therapy Research Paper

Liang-Liang Li, Li-Li Qu, Han-Jiang Fu, Xiao-Fei Zheng, Chuan-Hao Tang, Xiao-Yan Li, Jian Chen, Wei-Xia Wang, Shao-Xing Yang, Lin Wang, Guan-Hua Zhao, Pan-Pan Lv, Min Zhang, Yang-Yang Lei, Hai-Feng Qin, Hong Wang, Hong-Jun Gao, Xiao-Qing Liu

Published Apr 30, 2017 · Vol. 8, No. 28 · pp. 45399-45414

Meta-analysis comparing the efficacy of nedaplatin-based regimens between squamous cell and non-squamous cell lung cancers Meta-Analysis

Yijun Tian, Qian Liu, Kongju Wu, Qian Chu, Yuan Chen, Kongming Wu

Published Apr 28, 2017 · Vol. 8, No. 37 · pp. 62330-62338

Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy Research Paper

Mary Jo Fidler, Casey Frankenberger, Richard Seto, Gabriela C. Lobato, Cristina L. Fhied, Selina Sayidine, Sanjib Basu, Mark Pool, Reem Karmali, Marta Batus, Wen-Rong Lie, David Hayes, Jehangir Mistry, Philip Bonomi, Jeffrey A. Borgia

Published Apr 28, 2017 · Vol. 8, No. 35 · pp. 58108-58121

Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials Review

Michael Troncone, Stephanie M. Cargnelli, Linda A. Villani, Naghmeh Isfahanian, Lindsay A. Broadfield, Laura Zychla, Jim Wright, Gregory Pond, Gregory R. Steinberg, Theodoros Tsakiridis

Published Apr 27, 2017 · Vol. 8, No. 34 · pp. 57733-57754

Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer Research Paper

Guo-Jun Lu, Cheng-Jie Shao, Yu Zhang, Yong-Yue Wei, Wei-Ping Xie, Hui Kong

Published Apr 27, 2017 · Vol. 8, No. 30 · pp. 49217-49223

Dual-negative expression of Nrf2 and NQO1 predicts superior outcomes in patients with non-small cell lung cancer Research Paper

Ying-Hui Tong, Bo Zhang, You-You Yan, Yun Fan, Jia-Wen Yu, Si-Si Kong, Dan Zhang, Luo Fang, Dan Su, Neng-Ming Lin

Published Apr 25, 2017 · Vol. 8, No. 28 · pp. 45750-45758

Epidermal growth factor receptor-mutant lung cancer in Down syndrome: a case presentation and review of the literature Case Report

Xin Li, Shijiang Xing, Qiumei Dong

Published Apr 25, 2017 · Vol. 8, No. 33 · pp. 55760-55765

P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer Research Paper

Dongfang Tang, Lu Yue, Ruyong Yao, Lin Zhou, Yuqin Yang, Liming Lu, Wen Gao

Published Apr 25, 2017 · Vol. 8, No. 33 · pp. 54548-54557

Prognostic value of transglutaminase 2 in non-small cell lung cancer patients Research Paper

Zhu Chihong, Ling Yutian, Wan Danying, Jiang Ruibin, Sheng Huaying, Gu Linhui, Feng Jianguo

Published Apr 24, 2017 · Vol. 8, No. 28 · pp. 45577-45584

Evaluation of ^99mTc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC Research Paper

Zunyu Xiao, Yan Song, Wang Kai, Xilin Sun, Baozhong Shen

Published Apr 19, 2017 · Vol. 8, No. 25 · pp. 40732-40740

Survival benefit of immune checkpoint inhibitors according to the histology in non-small-cell lung cancer: A meta-analysis and review Meta-Analysis

Bum Jun Kim, Jung Han Kim, Hyeong Su Kim

Published Apr 19, 2017 · Vol. 8, No. 31 · pp. 51779-51785

ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells Research Paper

Arjan Kol, Anton Terwisscha van Scheltinga, Martin Pool, Christian Gerdes, Elisabeth de Vries, Steven de Jong

Published Apr 17, 2017 · Vol. 8, No. 28 · pp. 45432-45446

DDX23-Linc00630-HDAC1 axis activates the Notch pathway to promote metastasis Research Paper

Guozhang Mao, Hui Jin, Liuguang Wu

Published Apr 17, 2017 · Vol. 8, No. 24 · pp. 38937-38949

RACK1 promotes lung cancer cell growth via an MCM7/RACK1/Akt signaling complex Research Paper

Liangru Fei, Yinan Ma, Meiyu Zhang, Xiaofang Liu, Yuan Luo, Congcong Wang, Haiyan Zhang, Wenzhu Zhang, Yuchen Han

Published Apr 15, 2017 · Vol. 8, No. 25 · pp. 40501-40513

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1 Research Paper

A novel EGFR-TKI inhibitor (cAMP-H₃BO₃ complex) combined with thermal therapy is a promising strategy to improve lung cancer treatment outcomes Research Paper

Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC) Research Paper

Expression of glucose transporter 1 and prognosis in non-small cell lung cancer: a pooled analysis of 1665 patients Research Paper

Prognostic value of KRAS mutation in advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A meta-analysis and review Meta-Analysis

Mathematical modeling for Phase I cancer trials: A study of metronomic vinorelbine for advanced non-small cell lung cancer (NSCLC) and mesothelioma patients Research Paper

Circulating microRNAs as novel biomarkers of ALK-positive non-small cell lung cancer and predictors of response to crizotinib therapy Research Paper

Meta-analysis comparing the efficacy of nedaplatin-based regimens between squamous cell and non-squamous cell lung cancers Meta-Analysis

Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy Research Paper

Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials Review

Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer Research Paper

Dual-negative expression of Nrf2 and NQO1 predicts superior outcomes in patients with non-small cell lung cancer Research Paper

Epidermal growth factor receptor-mutant lung cancer in Down syndrome: a case presentation and review of the literature Case Report

P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer Research Paper

Prognostic value of transglutaminase 2 in non-small cell lung cancer patients Research Paper

Evaluation of ^99mTc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC Research Paper

Survival benefit of immune checkpoint inhibitors according to the histology in non-small-cell lung cancer: A meta-analysis and review Meta-Analysis

ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells Research Paper

DDX23-Linc00630-HDAC1 axis activates the Notch pathway to promote metastasis Research Paper

RACK1 promotes lung cancer cell growth via an MCM7/RACK1/Akt signaling complex Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1 Research Paper

A novel EGFR-TKI inhibitor (cAMP-H3BO3 complex) combined with thermal therapy is a promising strategy to improve lung cancer treatment outcomes Research Paper

Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC) Research Paper

Expression of glucose transporter 1 and prognosis in non-small cell lung cancer: a pooled analysis of 1665 patients Research Paper

Prognostic value of KRAS mutation in advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A meta-analysis and review Meta-Analysis

Mathematical modeling for Phase I cancer trials: A study of metronomic vinorelbine for advanced non-small cell lung cancer (NSCLC) and mesothelioma patients Research Paper

Circulating microRNAs as novel biomarkers of ALK-positive non-small cell lung cancer and predictors of response to crizotinib therapy Research Paper

Meta-analysis comparing the efficacy of nedaplatin-based regimens between squamous cell and non-squamous cell lung cancers Meta-Analysis

Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy Research Paper

Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials Review

Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer Research Paper

Dual-negative expression of Nrf2 and NQO1 predicts superior outcomes in patients with non-small cell lung cancer Research Paper

Epidermal growth factor receptor-mutant lung cancer in Down syndrome: a case presentation and review of the literature Case Report

P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer Research Paper

Prognostic value of transglutaminase 2 in non-small cell lung cancer patients Research Paper

Evaluation of 99mTc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC Research Paper

Survival benefit of immune checkpoint inhibitors according to the histology in non-small-cell lung cancer: A meta-analysis and review Meta-Analysis

ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells Research Paper

DDX23-Linc00630-HDAC1 axis activates the Notch pathway to promote metastasis Research Paper

RACK1 promotes lung cancer cell growth via an MCM7/RACK1/Akt signaling complex Research Paper

A novel EGFR-TKI inhibitor (cAMP-H₃BO₃ complex) combined with thermal therapy is a promising strategy to improve lung cancer treatment outcomes Research Paper

Evaluation of ^99mTc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC Research Paper